Rx Medicare

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced the initial results from the pilot section of its ongoing acetaminophen comparison study. The study, which is expected to be complete during early November, compares the effects of ActiPatch® Therapy to acetaminophen in the form of Extra Strength Tylenol® for the treatment of delayed onset muscle soreness (DOMS).

Read More…

Related Posts

• BioElectronics Announces Results Of Menstrual Pain Pilot Clinical Study
• SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus In Initial Pilot Animal Study
• BioElectronics Announces Tylenol(R) Comparative Study
• Comparative Effectiveness: Back Surgery Remains Popular Despite Poor Study Results
• Labopharm Reports Results For Phase III Study On Twice-daily Tramadol-acetaminophen Formulation
• Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
• Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• Phosphagenics Announces Positive Results From Phase 1B Study Of Transdermal Oxycodone Patch
• Introducing an online community into a clinical education setting: a pilot study of student and staff engagement and outcomes using blended learning
• Pilot study of a cognitive intervention program for persons with multiple sclerosis
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine
• ImmuneRegen BioSciences(R) Reports Additional Positive Results From Study Of Homspera(R) In Treating Highly Pathogenic Influenza
• BioElectronics Technology More Effective Than Extra Strength Tylenol(R) In Reducing Muscle Soreness In Clinical Study
• AcelRx Announces Positive Results From A Phase 2 Study Of ARX-03, A Sufentanil/Triazolam NanoTab For Procedural Sedation, Anxiolysis & Analgesia

Tags: acetaminophen, bioelectronics, comparative, pilot, results, section, study

This entry was posted on Tuesday, October 20th, 2009 at 8:10 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.